PolyPeptide Group AG (XSWX:PPGN) Other Long-Term Liabilities : CHF36.2 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Other Long-Term Liabilities?

PolyPeptide Group AG's other long-term liabilities for the quarter that ended in Dec. 2023 was CHF36.2 Mil.

PolyPeptide Group AG's quarterly other long-term liabilities declined from Dec. 2022 (CHF13.6 Mil) to Jun. 2023 (CHF13.0 Mil) but then increased from Jun. 2023 (CHF13.0 Mil) to Dec. 2023 (CHF36.2 Mil).

PolyPeptide Group AG's annual other long-term liabilities declined from Dec. 2021 (CHF16.6 Mil) to Dec. 2022 (CHF13.6 Mil) but then increased from Dec. 2022 (CHF13.6 Mil) to Dec. 2023 (CHF36.2 Mil).

PolyPeptide Group AG Other Long-Term Liabilities Historical Data

The historical data trend for PolyPeptide Group AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Other Long-Term Liabilities Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial					-	-	-	-	-

PolyPeptide Group AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

PolyPeptide Group AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines